Our data therefore suggest that the aberrant expression of CPSF1, HDAC6 and DNMT in cancer may cause promoter occlusion of RASSF1A. This is consistent with results from our previous studies, which indicate that histone deacetylation precedes the hypermethylation of the RASSF1A promoter43. Here, RASSF1 is linked to cancer.